Home Page
-
Basic Sciences celebrates its 2023–24 Russell G. Hamilton Graduate Leadership Institute awardees
The Russell G. Hamilton Graduate Leadership Institute, an initiative from the Vanderbilt University Graduate School, recognized over 130 students from the School of Medicine Basic Sciences with awards during the 2023–24 academic year. Read MoreJun. 21, 2024
-
NSF names 9 biomedical science students and alumni as 2024 graduate research fellows
The prestigious fellowship program assists exceptional graduate students pursuing research-based master’s and doctoral degrees across various fields, including science, technology, engineering, mathematics, STEM education and social sciences supported by NSF. Read MoreJun. 21, 2024
-
Vanderbilt’s Donna Ingles named to prestigious Harvard leadership program to advance Nashville’s biomedical sector
Ingles is among 10 Middle Tennessee leaders chosen for an intensive workshop this summer, which aims to create a biomedical economic development strategy for the region using cluster models devised by Harvard economist Michael Porter. The leaders represent corporate, academic, government and nonprofit organizations. Read MoreJun. 20, 2024
-
Hinton, Nolan, Vue recognized at 2024 Spring Postdoc Awards Ceremony
At the Spring Postdoc Awards Ceremony on May 23, the Office of Postdoctoral Affairs in partnership with the Vanderbilt Postdoctoral Association announced the 2024 award winners, who will also be highlighted in the Graduate School Sesquicentennial time capsule to be opened in 2074. Read MoreJun. 17, 2024
-
Diabetes Day spotlights achievements, current investigations
Today, the Vanderbilt Diabetes Research and Training Center includes 140 faculty members from 15 departments and three colleges or schools at Vanderbilt and Meharry Medical College who conduct basic, clinical and translational research on the cause, prevention, treatment and complications of diabetes and obesity. Read MoreJun. 12, 2024
-
Obesity-cancer connection discovery suggests strategies for improving immunotherapy
The study reported in the journal Nature provides a mechanistic explanation for the “obesity paradox” — that obesity can contribute to cancer progression but also improve response to immunotherapy. Read MoreJun. 12, 2024
-
Putting the fun back in antifungals: new insights into Acanthamoeba drug targets
Acanthamoeba can cause diseases blinding keratitis, an infection of the eye, or granulomatous amebic encephalitis, a generally fatal infection of the brain and spinal cord. Antifungals that target the biosynthesis of fungal sterols, such as ergosterol, are often used as treatment, but the Acanthamoeba ergosterol biosynthetic pathway has been shown to differ significantly from that found in fungi. Read MoreJun. 12, 2024
-
Chancellor announces 2024 Faculty Fellows, grants $40,000 per year to support scholarship and research
Calipari, Spraggins, and Kirabo are among 13 outstanding faculty members who have been selected for the 2024 cohort of Chancellor Faculty Fellows. Read MoreJun. 11, 2024
-
New drug candidates targeting blood clots developed through computer-aided drug design
Using computer-aided drug design, the labs of Heidi Hamm, Jens Meiler, and Craig Lindsley generated a novel series of biologically active compounds that can serve as a basis for anti–blood clot preventative drugs. Read MoreJun. 6, 2024
-
Q&A: Reviewing systemic problems for autistic adults in STEMM
AJ Hinton, Amber Crabtree, and colleagues collaborated to provide a commentary on the challenges facing autistic adults in science, technology, engineering, math, and medicine. As autistic adults face a high unemployment rate, the authors argue that solutions are necessary to evoke change within STEMM institutions to acquire and retain autistic employees. Read MoreJun. 5, 2024